Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Assets Average (2021 - 2026)

Invivyd's (IVVD) quarterly Assets Average came in at $247.9 million in Q2 2026, up 157.03% on a YoY basis from $96.4 million in Q2 2025, and up 19.16% quarter-over-quarter from $208.0 million in Q4 2025.

Analysis

Invivyd (IVVD) Assets Average (2021 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Assets Average for 6 consecutive years, with $247.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Assets Average rose 157.03% year-over-year to $247.9 million; the trailing twelve-month figure through Jun 2026 stood at $247.9 million (up 157.03% YoY), and the FY2025 full-year result was $203.2 million, up 13.3% from the prior year.
  • Assets Average advanced to $247.9 million in Q2 2026 per IVVD's latest filing, from $208.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $588.2 million in Q1 2022 and bottomed at $96.4 million in Q2 2025.
  • Historically, Assets Average has averaged $278.3 million across 5 years, with a median of $247.9 million in 2026.
  • The sharpest annual moves came in 2025 and 2026: Assets Average slumped 50.9% in 2025, then jumped 157.03% in 2026.
  • Over 5 years, Assets Average stood at $404.0 million in 2022, then slumped by 37.6% to $252.0 million in 2023, then slumped by 42.19% to $145.7 million in 2024, then jumped by 42.76% to $208.0 million in 2025, then increased by 19.16% to $247.9 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $247.9 million, $208.0 million, and $114.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 5.34 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 30.78 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 2.09 Bn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 247.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 247.88 Mn
Dec 31, 2025 208.02 Mn
Sep 30, 2025 114.15 Mn
Jun 30, 2025 96.44 Mn
Mar 31, 2025 116.63 Mn
Dec 31, 2024 145.72 Mn
Sep 30, 2024 169.63 Mn
Jun 30, 2024 196.41 Mn
Mar 31, 2024 222.32 Mn
Dec 31, 2023 252.05 Mn
Sep 30, 2023 295.17 Mn
Jun 30, 2023 332.99 Mn
Mar 31, 2023 366.87 Mn
Dec 31, 2022 403.96 Mn
Sep 30, 2022 454.68 Mn
Jun 30, 2022 520.44 Mn
Mar 31, 2022 588.18 Mn
Dec 31, 2021 653.18 Mn
Sep 30, 2021 542.13 Mn